James Marcetich, Head of MEDLINE Index Section, says that a 
growing number of journal supplements are funded by drug 
companies but do not disclose that the companies have paid 
some authors to write about their products. In January 
2007, supplements will have to describe authors' relevant 
corporate ties or they will not be indexed.